Filter
529
Filtered Results: 529
Text search:
molecular
markers
Featured
Recommendations
68
New Publications
104
Language
Document type
No document type
242
Guidelines
112
Studies & Reports
98
Manuals
36
Strategic & Response Plan
18
Fact sheets
10
Training Material
7
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
43
Global
23
Africa
14
Latin America and the Carribbean
13
Kenya
12
Tanzania
12
Western and Central Europe
12
Ethiopia
8
Eastern Europe
8
South Africa
7
South–East Asia Region
6
Philippines
5
East and Southern Africa
5
West and Central Africa
5
Sierra Leone
4
Nigeria
4
Uganda
4
Zimbabwe
4
Indonesia
4
Western Pacific Region
4
Asia
4
Cameroon
3
Nepal
3
Pakistan
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
USA
2
Zambia
2
Syria
2
Benin
2
Ukraine
2
Middle East and North Africa
2
Venezuela
2
North America
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Somalia
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Cambodia
1
Thailand
1
China
1
Rwanda
1
Malaysia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Angola
1
Lesotho
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Japan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
97
Public Health
38
Pharmacy & Technologies
24
Key Resources
14
Women & Child Health
12
Capacity Building
4
Toolboxes
TB
75
COVID-19
56
AMR
48
HIV
36
NTDs
31
Rapid Response
29
Mental Health
28
Planetary Health
17
NCDs
14
Ebola
10
Refugee
8
Pharmacy
8
Polio
5
Zika
5
Specific Hazards
4
Cholera
3
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Natural Hazards
2
Health Financing Toolbox
1
The Lancet Planetary Health Volume 5, ISSUE 7, e466-e478, July 01, 2021
Transmission of many infectious diseases depends on interactions between humans, animals, and the environment. Incorporating these complex processes in transmission dynamic models can help inform policy and disease control int...
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the human-animal-envi...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
The biosphere underlies the whole sustainable development concept, as the layer on
which society and the economy rely. Nature and biodiversity fuel the natural cycles
and life-support systems of the planet, on which humanity ultimately depends.
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to ongoing climate change. Allergic diseases have been increasing in prevalence over the last decades, partly as the result of the impact of climate change. ...
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a...
This open access book not only describes the challenges of climate disruption, but also presents solutions. The challenges described include air pollution, climate change, extreme weather, and related health impacts that range from heat stress, vector-borne diseases, food and water insecurity and ch...
Constraints, Technologies, Policies and Processes
WHO Technical Series 971
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Vol.399 Issue 10341 p.2129-2154
Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 s...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
